PATH vs. DOCU, ESTC, DUOL, GEN, PCOR, CFLT, SPSC, KVYO, BRZE, and CXM
Should you be buying UiPath stock or one of its competitors? The main competitors of UiPath include DocuSign (DOCU), Elastic (ESTC), Duolingo (DUOL), Gen Digital (GEN), Procore Technologies (PCOR), Confluent (CFLT), SPS Commerce (SPSC), Klaviyo (KVYO), Braze (BRZE), and Sprinklr (CXM). These companies are all part of the "prepackaged software" industry.
DocuSign (NASDAQ:DOCU) and UiPath (NYSE:PATH) are both large-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership.
DocuSign received 287 more outperform votes than UiPath when rated by MarketBeat users. Likewise, 59.71% of users gave DocuSign an outperform vote while only 45.13% of users gave UiPath an outperform vote.
DocuSign has higher revenue and earnings than UiPath. UiPath is trading at a lower price-to-earnings ratio than DocuSign, indicating that it is currently the more affordable of the two stocks.
77.6% of DocuSign shares are held by institutional investors. Comparatively, 62.5% of UiPath shares are held by institutional investors. 1.7% of DocuSign shares are held by insiders. Comparatively, 22.4% of UiPath shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
DocuSign has a net margin of 2.68% compared to DocuSign's net margin of -6.87%. UiPath's return on equity of 13.91% beat DocuSign's return on equity.
DocuSign has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, UiPath has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.
DocuSign currently has a consensus price target of $60.25, suggesting a potential upside of 0.30%. UiPath has a consensus price target of $27.41, suggesting a potential upside of 34.97%. Given DocuSign's stronger consensus rating and higher probable upside, analysts clearly believe UiPath is more favorable than DocuSign.
In the previous week, UiPath had 11 more articles in the media than DocuSign. MarketBeat recorded 18 mentions for UiPath and 7 mentions for DocuSign. UiPath's average media sentiment score of 1.04 beat DocuSign's score of 0.70 indicating that DocuSign is being referred to more favorably in the media.
Summary
DocuSign beats UiPath on 11 of the 18 factors compared between the two stocks.
Get UiPath News Delivered to You Automatically
Sign up to receive the latest news and ratings for PATH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PATH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools